CHINA PHARMA HOLDINGS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $100.00K, a 83.61% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $600.00K, a 25.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $450.00K, a 30.77% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $610.00K, a 205.00% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $1.47M, a 48.70% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $2.86M, a 97.24% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.45M.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $864.48K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $1.47M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $600.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $450.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $2.86M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $610.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $800.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $650.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $1.45M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $200.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $300.00K 10-Q · filed 2023-11-13 | |
| 2021-09-30 | $1.18M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $864.48K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |